FILE - Vice President Mike Pence, flanked by administration officials, including Health and Human Services Secretary Alex Azar (L), speaks about the coronavirus outbreak, in the briefing room of the White House in Washington, March, 9, 2020.
FILE - Vice President Mike Pence, flanked by administration officials, including Health and Human Services Secretary Alex Azar (L), speaks about the coronavirus outbreak, in the briefing room of the White House in Washington, March, 9, 2020.

WASHINGTON - U.S. Vice President Mike Pence on Thursday defended the Trump administration's new restrictions on travel from European nations, saying the epicenter of the coronavirus has shifted from Asia to Europe.

In a round of television interviews, the Republican vice president said thousands more COVID-19 cases were expected in the United States, and that clamping down on European travelers was just part of the administration's strategy as U.S. cases swell.

The European Union on Thursday criticized the U.S. travel curbs, saying it was not consulted first before U.S. President Donald Trump announced them in a Wednesday night address to the nation.

Travellers wearing protective masks stand at Delta Air Lines ticketing desk at Paris Charles de Gaulle airport.
European Leaders Assail Trump Over Unilateral Flight Ban
Decision blocks flights from 26 countries to US for 30 days starting at Friday midnight - Britain and Ireland are excepted


Pence also said officials are seeking to ramp up testing in all 50 U.S. states and pointed to efforts by commercial laboratories including Laboratory Corporation of America Holdings (LabCorp) and Quest Diagnostics Inc, but gave no other details.

Health experts have said a shortage of diagnostic test kits has made it difficult to gauge the full scale of outbreaks in the United States and curtail transmission of the virus.

Gilead Sciences, Inc. CEO Daniel O'Day attends a meeting with President Donald Trump, members of the Coronavirus Task Force,…
Pentagon Strikes Deal With Biotech Firm to Make Coronavirus Drug Available to Troops
Under the agreement between Gilead and US Army, the drug will be provided to the Defense Department at no cost


The hardest-hit U.S. states, such as New York and Washington state, have struggled to quickly expand testing capacity to make such screening widely available.

Special Section